Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

Hoerger, T., Bethke, A., Richter, A., Sorensen, SW., Engelgau, M., Thompson, T., Narayan, KMV., Williamson, DF., Gregg, E., Zhang, P., Eastman, RC., Fuller, J., Gibbons, C., Haffner, S., Herman, WH., Howard, B., Ratner, R., & Orchard, T. (2002). Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA, 287(19), 2542-2551.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Consuming illicit opioids during a drug overdose epidemic
Article

News coverage about aspirin as a countervailing force against low-dose aspirin campaign promotion
Article

Cost, reach, and representativeness of recruitment efforts for an online skin cancer risk reduction intervention trial for young adults